To Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque Psoriasis | MicrobiomeTrials← Back to trialsNCT07008547
To Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque Psoriasis
CompletedPHASE3INTERVENTIONAL
Trial Details
Start: 2024-07-30Est. Completion: 2025-03-28
Enrollment target: 202 participants Locations- Peking University People's Hospital, Beijing, Beijing Municipality, China
Other microbiome trials you might be interested in
Psoriasis
The main purpose of this study is to evaluate the long-term safety and efficacy of the drug Deucravacitinib (BMS-986165)…
Birmingham, United StatesCompleted Jul 21, 2026
Chronic Plaque Psoriasis
This study will assess the safety and efficacy of ARQ-151 cream applied once a day for 24 weeks by subjects with chronic…
Scottsdale, United StatesCompleted Jan 22, 2024